scuPA/suPAR (Thrombotech)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NamescuPA/suPAR (Thrombotech)

Drug Alias NameSingle-chain urokinase plasminogen activator/recombinant soluble urokinase cellular receptor complex (Thrombotech)thrombolytic agent (Thrombotech)

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionUrokinase plasminogen activator stimulants

TargetsUrokinase plasminogen activator

Therapy Area/IndicationsMyocardial InfarctionStroke

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryIsrael

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesThrombotech Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesThrombotech Ltd

Active IndicationsN/A

Inactive IndicationsMyocardial InfarctionStroke

Other Information

ATC CodeN/A